相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Olaparib monotherapy as primary treatment in unselected triple negative breast cancer
H. P. Eikesdal et al.
ANNALS OF ONCOLOGY (2021)
BRCA1 promoter methylation in peripheral blood is associated with the risk of triple-negative breast cancer
Karolina Prajzendanc et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Circulating breast-derived DNA allows universal detection and monitoring of localized breast cancer
J. Moss et al.
ANNALS OF ONCOLOGY (2020)
DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types
Vera Constancio et al.
CELLS (2020)
Circulating tumor DNA (ctDNA) is not a good proxy for liquid biopsies of tumor tissues for early detection
Clare Fiala et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
The association between the methylation frequency of BRCA1/2 gene promoter and occurrence and prognosis of breast carcinoma A meta-analysis
Shu Li et al.
MEDICINE (2020)
BRCA1 Promoter Hypermethylation is Associated with Good Prognosis and Chemosensitivity in Triple-Negative Breast Cancer
William Jacot et al.
CANCERS (2020)
DNA methylation disruption reshapes the hematopoietic differentiation landscape
Franco Izzo et al.
NATURE GENETICS (2020)
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
M. C. Liu et al.
ANNALS OF ONCOLOGY (2020)
Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
Dominik Glodzik et al.
NATURE COMMUNICATIONS (2020)
BRCA1 Promoter Methylation Status in 1031 Primary Breast Cancers Predicts Favorable Outcomes Following Chemotherapy
Olafur A. Stefansson et al.
JNCI CANCER SPECTRUM (2020)
The epigenetic clock as a predictor of disease and mortality risk: a systematic review and meta-analysis
Peter D. Fransquet et al.
CLINICAL EPIGENETICS (2019)
Clonal hematopoiesis in human aging and disease
Siddhartha Jaiswal et al.
SCIENCE (2019)
Constitutive BRCA1 Promoter Hypermethylation Can Be a Predisposing Event in Isolated Early-Onset Breast Cancer
Jacopo Azzollini et al.
CANCERS (2019)
Comorbid and inflammatory characteristics of genetic subtypes of clonal hematopoiesis
Elina K. Cook et al.
BLOOD ADVANCES (2019)
Constitutional Mosaic Epimutations - a hidden cause of cancer?
Per E. Lonning et al.
CELL STRESS (2019)
DNA methylation-based biological aging and cancer risk and survival: Pooled analysis of seven prospective studies
Pierre-Antoine Dugue et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification
L. Liu et al.
ANNALS OF ONCOLOGY (2018)
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen et al.
SCIENCE (2018)
Methylation of BRCA1 and MGMT genes in white blood cells are transmitted from mothers to daughters
Nisreen Al-Moghrabi et al.
CLINICAL EPIGENETICS (2018)
Increased epigenetic age in normal breast tissue from luminal breast cancer patients
Erin W. Hofstatter et al.
CLINICAL EPIGENETICS (2018)
Sensitive tumour detection and classification using plasma cell-free DNA methylomes
Shu Yi Shen et al.
NATURE (2018)
BRCA1 methylation in newborns: genetic disposition, maternal transfer, environmental influence, or by chance only?
Per Eystein Lonning et al.
CLINICAL EPIGENETICS (2018)
Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008
Roisin M. Connolly et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
DNA methylome analysis identifies accelerated epigenetic ageing associated with postmenopausal breast cancer susceptibility
Srikant Ambatipudi et al.
EUROPEAN JOURNAL OF CANCER (2017)
Patient monitoring through liquid biopsies using circulating tumor DNA
Peter Ulz et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study
Kala Visvanathan et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Christopher Abbosh et al.
NATURE (2017)
Direct detection of early-stage cancers using circulating tumor DNA
Jillian Phallen et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Incorporating BEAMing technology as a liquid biopsy into clinical practice for the management of colorectal cancer patients: an expert taskforce review
J. Garcia-Foncillas et al.
ANNALS OF ONCOLOGY (2017)
Follow-up of patients with localized breast cancer and first indicators of advanced breast cancer recurrence: A retrospective study
Julien Viot et al.
BREAST (2017)
The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer
Weigang Wang et al.
CLINICA CHIMICA ACTA (2017)
Epigenome-wide association studies for cancer biomarker discovery in circulating cell-free DNA: technical advances and challenges
Miljana Tanic et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2017)
Obesity and the breast cancer methylome
William B. Coleman
CURRENT OPINION IN PHARMACOLOGY (2016)
Methylated circulating tumor DNA in blood: power in cancer prognosis and response
Kristina Warton et al.
ENDOCRINE-RELATED CANCER (2016)
Liquid biopsy: Potential and challenges
Klaus Pantel et al.
MOLECULAR ONCOLOGY (2016)
Integrated digital error suppression for improved detection of circulating tumor DNA
Aaron M. Newman et al.
NATURE BIOTECHNOLOGY (2016)
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
Catherine Alix-Panabieres et al.
CANCER DISCOVERY (2016)
Blood-based DNA methylation as biomarker for breast cancer: a systematic review
Qiuqiong Tang et al.
CLINICAL EPIGENETICS (2016)
Genome-wide DNA methylation profiling in triple-negative breast cancer reveals epigenetic signatures with important clinical value
Clare Stirzaker et al.
MOLECULAR & CELLULAR ONCOLOGY (2016)
Methylation analyses in liquid biopsy
Delphine Lissa et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2016)
Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value
Clare Stirzaker et al.
NATURE COMMUNICATIONS (2015)
Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients
Jordan Madic et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Novel Methylated Biomarkers and a Robust Assay to Detect Circulating Tumor DNA in Metastatic Breast Cancer
Mary Jo Fackler et al.
CANCER RESEARCH (2014)
Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin
Katherine A. Hoadley et al.
CELL (2014)
Frequent promoter hypermethylation and expression reduction of the glucocorticoid receptor gene in breast tumors
Kirsten A. Nesset et al.
EPIGENETICS (2014)
Liquid Biopsies: Genotyping Circulating Tumor DNA
Luis A. Diaz et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
WRITTEN IN BLOOD DNA circulating in the bloodstream could guide cancer treatment - if researchers can work out how best to use it
Ed Yong
NATURE (2014)
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Aaron M. Newman et al.
NATURE MEDICINE (2014)
BiQ Analyzer HiMod: an interactive software tool for high-throughput locus-specific analysis of 5-methylcytosine and its oxidized derivatives
Daniel Becker et al.
NUCLEIC ACIDS RESEARCH (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
Daniel A. Haber et al.
CANCER DISCOVERY (2014)
Promoter methylation of BRCA1 in triple-negative breast cancer predicts sensitivity to adjuvant chemotherapy
Y. Xu et al.
ANNALS OF ONCOLOGY (2013)
Interplay between the Cancer Genome and Epigenome
Hui Shen et al.
CELL (2013)
Liquid biopsy: monitoring cancer-genetics in the blood
Emily Crowley et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
A Reference Methylome Database and Analysis Pipeline to Facilitate Integrative and Comparative Epigenomics
Qiang Song et al.
PLOS ONE (2013)
Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction
Jian Ye et al.
BMC BIOINFORMATICS (2012)
DNA Methylation Screening Identifies Driver Epigenetic Events of Cancer Cell Survival
Daniel D. De Carvalho et al.
CANCER CELL (2012)
BEAMing Up Personalized Medicine: Mutation Detection in Blood
Andrea L. Richardson et al.
CLINICAL CANCER RESEARCH (2012)
The importance of examining the proportion of circulating DNA originating from tumor, microenvironment and normal cells in colorectal cancer patients
Florent Mouliere et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
RNase H-dependent PCR (rhPCR): improved specificity and single nucleotide polymorphism detection using blocked cleavable primers
Joseph R. Dobosy et al.
BMC BIOTECHNOLOGY (2011)
BiQ Analyzer HT: locus-specific analysis of DNA methylation by high-throughput bisulfite sequencing
Pavlo Lutsik et al.
NUCLEIC ACIDS RESEARCH (2011)
High Fragmentation Characterizes Tumour-Derived Circulating DNA
Florent Mouliere et al.
PLOS ONE (2011)
BRCA1 CpG Island Hypermethylation Predicts Sensitivity to Poly(Adenosine Diphosphate)-Ribose Polymerase Inhibitors
Jurgen Veeck et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns
Karolina Holm et al.
BREAST CANCER RESEARCH (2010)
Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer
Theo deVos et al.
CLINICAL CHEMISTRY (2009)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer
Mohammad O. Hoque et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
BiQ analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing
C Bock et al.
BIOINFORMATICS (2005)
The human genome browser at UCSC
WJ Kent et al.
GENOME RESEARCH (2002)
分享论文
